EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASE
- 1 February 1983
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 321 (8320) , 315-317
- https://doi.org/10.1016/s0140-6736(83)91625-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Double-Blind Controlled Clinical Trial of Ancrod for Ischemic Rest Pain of the LegAngiology, 1982
- A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial diseaseThrombosis Research, 1981
- Serial Platelet Survival Half-Life (PS) In Peripheral Vascular Disease And Diabetes MellitusPublished by Georg Thieme Verlag KG ,1981
- Platelet Activation During Treadmill Exercise In Patients With Chronic Peripheral Arterial DiseasePublished by Georg Thieme Verlag KG ,1981
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- Increased platelet aggregates in vascular and non-vascular illness: Correlation with plasma fibrinogen and effect of ancrodThrombosis Research, 1979
- Anti-platelet action of intravenous infusion of prostacyclin in manThrombosis Research, 1978
- Reconstructive Surgery in GangreneScottish Medical Journal, 1976
- Simultaneous Flow and Pressure Measurements in Intermittent ClaudicationBritish Journal of Surgery, 1972